SET6 (systematic name YPL165C) is a 373-residue Saccharomyces cerevisiae protein belonging to the SET-domain (Su(var)3-9, Enhancer-of-zeste, Trithorax) class of the class V-like SAM-binding methyltransferase superfamily. It is one of the two budding-yeast members of the SMYD subfamily (its paralog being Set5) and is annotated as a putative protein-lysine methyltransferase. Its SET domain retains the invariant catalytic and S-adenosyl-L-methionine-binding residues that the catalytically dead yeast SET proteins Set3 and Set4 have lost, so SET6 is considered a likely catalytically competent enzyme, and it carries a cysteine-rich SMYD-type zinc-binding architecture. However, no methyltransferase activity, protein substrate, subcellular localization, or defined biological role has been experimentally established for SET6; the only reported phenotype is a drug-conditional fitness effect (resistance to compounds targeting ergosterol biosynthesis) from a genome-wide chemogenomic screen, whose molecular basis is unclear.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
| GO:0016279 protein-lysine N-methyltransferase activity | IBA GO_REF:0000033 | ACCEPT | Summary: Best-supported molecular function for SET6: a putative, likely catalytically competent protein-lysine methyltransferase. The SET/SMYD active site is intact (unlike Set3/Set4) and the literature singles out Set6 as the yeast SET protein most likely to be a genuine protein methyltransferase. Retained as the enzyme's likely core activity, while noting that no methyltransferase activity or substrate has been demonstrated. Reason: Phylogenetically inferred (IBA) but strongly corroborated. On sequence, SET6 retains the invariant catalytic/SAM-binding residues (NHSC pocket, catalytic Tyr337) that the catalytically dead Set3/Set4 have lost, and the literature explicitly calls Set6 the most likely genuine yeast protein methyltransferase. This lysine-KMT level (rather than the more specific histone-MTase term) is the defensible molecular function and best available core-function call. It remains putative because no in-vitro/in-vivo activity or substrate has been shown. Propagation Review Root cause: NO FAILURE CORE Sources checked: PANTHER:PTN008534456 · SMYD-family PANTHER node in PTHR12197 SUPPORTS TRANSFER PAINT places this broad lysine-methyltransferase IBD on the SMYD node that contains S. cerevisiae SET6. The family supports SET-domain protein-lysine methyltransferase activity even though the precise SET6 substrate is unknown. Supporting Evidence: PMID:37252976 Of these three putative methyltransferases, the most likely protein methyltransferase is Set6, as the SET domain invariably methylates proteins. file:yeast/SET6/SET6-bioinformatics/RESULTS.md The invariant Asn-His of the "NHSC" AdoMet/catalytic motif is **conserved in SET6** (Asn303-His304-Ser305-Cys306), exactly as in the active enzymes Set1, Set2, Set5, SMYD2 and SMYD3. |
| GO:0042054 histone methyltransferase activity | IBA GO_REF:0000033 | MARK AS OVER ANNOTATED | Summary: Over-specific substrate assignment. The defensible function for SET6 is protein-lysine methyltransferase activity (GO:0016279); SET6 has no demonstrated histone substrate or, indeed, any known substrate. Its same-organism paralog Set5 is an H4 lysine methyltransferase and mammalian SMYD proteins have both histone and non-histone targets, so the histone-specific term is an over-annotation for uncharacterized SET6 itself. Reason: This IBA term over-specifies the substrate to histones. Set6 has no identified substrate of any kind; Set5 is an H4 lysine methyltransferase and mammalian SMYD proteins have both histone and non-histone targets, but neither the same-organism paralog nor the broader SMYD donor set establishes that SET6 itself uses histones as substrates. The parent-level protein-lysine methyltransferase activity (GO:0016279) already captures the family-inferred function without the unwarranted histone specificity. Prefer the generic KMT term over this one. Propagation Review Root cause: TERM SCOPING PROBLEM Failure modes: GRANULARITY MISMATCH Sources checked: PANTHER:PTN008534456 · SMYD-family PANTHER node (PTHR12197) from which the IBA histone-MTase term was propagated NOT RELEVANT This is the ancestral PAINT node that carries the histone-methyltransferase IBD; the curated source genes, rather than the node itself, determine whether the histone-specific substrate class transfers to SET6. SGD:S000001250 · Set5/YHR207C SUPPORTS SOURCE BUT NOT TARGET Set5 is a characterized S. cerevisiae SMYD-family histone H4 lysine methyltransferase, so the source annotation is sound; the same-organism paralog does not establish the same histone specificity for SET6, whose substrate is unknown. Proposed replacements: protein-lysine N-methyltransferase activity Supporting Evidence: PMID:31642774 Set5, and another member of this sub-group, Set6, are homologous to the mammalian SMYD proteins [6], which have been reported to have both histone and non-histone targets. PMID:37252976 If they are in fact protein methyltransferases, they are most likely to target as-yet undiscovered methylation sites |
| GO:0005634 nucleus | IBA GO_REF:0000033 | KEEP AS NON CORE | Summary: Plausible location by SMYD-family phylogenetic transfer, but the subcellular localization of Set6 has never actually been measured, so this is a low-confidence, non-core annotation. Its paralog Set5 is found in both nucleus and cytoplasm. Reason: IBA family transfer to nucleus is reasonable for a SET/SMYD protein, but the localization of Set6 specifically is explicitly unknown, and its SMYD paralog Set5 is in fact dual nuclear/cytoplasmic, which would be consistent with non-histone substrates. Retain as a non-core, unverified location rather than a defining feature. Propagation Review Root cause: NO FAILURE NON CORE Sources checked: PANTHER:PTN008534456 · SMYD-family PANTHER node in PTHR12197 NOT RELEVANT This is the ancestral PAINT node carrying the nucleus IBD; the curated source genes, rather than the node itself, are the relevant evidence for the transfer. SGD:S000001250 · Set5/YHR207C SUPPORTS TRANSFER Set5 is the characterized same-organism SMYD paralog of SET6 and has direct evidence for both nucleus and cytoplasm; this supports nucleus as a plausible, non-exclusive localization for SET6, whose own localization has not been measured. Supporting Evidence: PMID:31642774 While the subcellular localization of Set6 is not yet known, Set5 is found in both the nucleus and cytoplasm [19], suggesting it is also likely to have non-histone substrates. |
| GO:0006338 chromatin remodeling | IEA GO_REF:0000108 | REMOVE | Summary: Automatic inter-ontology inference chained off the over-annotated histone methyltransferase term. There is no evidence that Set6 participates in chromatin remodeling; the biological process is unknown. Remove along with its over-specific parent MF term. Reason: This IEA annotation is derived by logical inference (GO_REF:0000108) from GO:0042054 histone methyltransferase activity (see the with/from field GO:0042054 in GOA), which is itself an over-annotation for SET6. Set6 has no demonstrated histone activity, no identified substrate, and no measured chromatin role; deletion has no standalone growth phenotype. The inference collapses once the histone-MTase premise is removed, so the chromatin-remodeling process assignment is unsupported and should be removed. Propagation Review Root cause: TERM SCOPING PROBLEM Failure modes: GRANULARITY MISMATCH Sources checked: GO:0042054 · histone methyltransferase activity (the over-annotated MF term this IEA process was logically inferred from) SOURCE WEAK OR INFERRED The inter-ontology IEA process is chained off an over-specific, itself-inferred MF term; it has no independent support for a chromatin role in Set6. Supporting Evidence: PMID:37252976 If they are in fact protein methyltransferases, they are most likely to target as-yet undiscovered methylation sites |
| GO:0008270 zinc ion binding | RCA PMID:30358795 The cellular economy of the Saccharomyces cerevisiae zinc pr... | KEEP AS NON CORE | Summary: Computational (zinc-proteome) prediction that SET6 binds zinc, independently corroborated by its cysteine-rich SMYD-type zinc-knot/post-SET architecture. A plausible structural molecular function; kept as non-core because it is a structural, not the defining, activity. Reason: The RCA annotation comes from a genome-scale zinc-proteome analysis. It is supported by the local bioinformatics finding that SET6 is markedly Cys-rich (17 Cys, 4.6%) in three clusters (N-terminal CxxC, an internal-insert cluster, and a C-terminal post-SET C-x-C...C) matching the expected SMYD-family zinc-binding architecture. This is a structural cofactor-binding function typical of SMYD SET domains rather than SET6's defining catalytic activity, so it is retained as non-core. Supporting Evidence: file:yeast/SET6/SET6-bioinformatics/RESULTS.md This clustered pattern is the expected SMYD-family zinc-knot / post-SET metal-binding architecture and is consistent with the computational zinc-ion-binding prediction (RCA, PMID:30358795). |
| GO:0005575 cellular_component | ND GO_REF:0000015 | ACCEPT | Summary: Root cellular_component term with the ND (No biological Data) evidence code, used as a placeholder indicating no localization data. Accept as-is per GO convention. Reason: This is a standard ND root-term placeholder recording that no cellular-component data is available; it is not an informative annotation to modify or remove. The gene's search record (SET6-notes.md) finds no study that localizes SET6. Supporting Evidence: file:yeast/SET6/SET6-notes.md Subcellular localization is unmeasured: |
| GO:0008150 biological_process | ND GO_REF:0000015 | ACCEPT | Summary: Root biological_process term with the ND evidence code, a placeholder indicating no process data. Accept as-is per GO convention. Reason: Standard ND root-term placeholder recording that no biological-process data is available for SET6; not an informative annotation to modify or remove. Possibly stale: the 2026-11-06 ND citation pass found literature on this gene in this species that may identify a biological process; see SET6-notes.md, section "ND literature-search citations (2026-11-06)". A curator should check it before this ACCEPT stands. |
Loading supporting content…
Download this section (compressed HTML)Q: Does SET6 catalyze protein-lysine methylation, and if so, what is its physiological protein substrate - a histone, or (as its SMYD family suggests) a non-histone target?
Suggested experts: Hamey JJ, Wilkins MR
Q: What is the subcellular localization of SET6, and does it (like its paralog Set5) distribute between the nucleus and cytoplasm, consistent with a non-histone substrate?
Suggested experts: Green EM
Experiment: Perform heavy-methyl SILAC quantitative mass spectrometry comparing the methylproteome of a wild-type strain with a set6-delta strain to identify SET6-dependent methylation site(s); confirm candidates with in-vitro methyltransferase assays using recombinant SET6, AdoMet, and active-site point mutants as negative controls.
Hypothesis: SET6 is a catalytically active protein-lysine methyltransferase whose substrate is a (likely non-histone) yeast protein.
Type: comparative methylproteomics + in-vitro methyltransferase assay
Experiment: Recombinantly express wild-type SET6 and NHSC-pocket / catalytic-Tyr337 point mutants and compare methyl-transfer activity against a candidate substrate panel to test whether the conserved residues are functionally required.
Hypothesis: SET6 retains intact catalytic residues, so active-site mutation should abolish any detectable methyltransferase activity.
Type: structure-function mutagenesis
Experiment: Endogenously tag SET6 with a fluorescent protein and image its subcellular distribution across growth conditions, including in the presence of ergosterol-biosynthesis inhibitors that produce its chemogenomic phenotype.
Hypothesis: SET6 localizes within the yeast cell in a pattern consistent with its (unknown) substrate compartment.
Type: fluorescence microscopy / localization
What is not known — curated, literature-grounded statements of the open unknowns (the inverse of core functions).
Gap: The protein substrate of SET6 is unknown: no methylation site on any histone or non-histone protein has ever been attributed to SET6, so the specific methyl-acceptor it acts on is undetermined.
OPEN BIOLOGY MF_DARK
What is known: Established: SET6 is a SMYD-subfamily SET-domain protein whose catalytic/SAM-binding residues are intact (unlike the dead Set3/Set4), and it is the yeast SET protein most likely to be a genuine protein-lysine methyltransferase. Unknown: which protein (and which lysine) it methylates. If it is active, it most likely targets an as-yet undiscovered methylation site.
Significance: SET6 is one of only a handful of putative protein methyltransferases keeping the otherwise near-complete yeast protein-methylation enzyme-substrate network incomplete; identifying its substrate would help close that network.
What would resolve it: In-vitro methyltransferase assays with recombinant SET6 against candidate substrates and heavy-methyl SILAC / mass-spectrometry comparison of wild-type vs set6-delta methylproteomes to detect SET6-dependent methylation site(s).
Provenance (the field's own admissions):
Gap: Whether SET6 actually catalyzes methyl transfer in vitro or in vivo has never been demonstrated; its catalytic competence is inferred solely from conserved active-site residues.
OPEN BIOLOGY MF_DARK
What is known: Established: the SET-domain active-site residues required for catalysis and AdoMet binding are conserved in SET6, unlike in the catalytically dead Set3/Set4. Unknown: whether SET6 transfers a methyl group to any acceptor. Sequence conservation is necessary but not sufficient for enzymatic activity.
Significance: Confirming (or refuting) methyltransferase activity would resolve whether SET6 is a bona fide enzyme or, despite intact motifs, another inactive yeast SET protein.
What would resolve it: Direct enzymatic assay (radiometric or MS-based methyl-transfer) using recombinant SET6 and AdoMet, with active-site point mutants as controls.
Provenance (the field's own admissions):
Gap: The biological role and subcellular localization of SET6 are unknown: deletion produces no standalone growth phenotype, and where in the cell SET6 acts has not been measured.
OPEN BIOLOGY BP_DARK
What is known: Established: the only reported phenotype is drug-conditional fitness (resistance to ergosterol-biosynthesis-targeting compounds) in a chemogenomic screen, of uncertain mechanism, and SET6's SMYD paralog Set5 is dual nuclear/cytoplasmic. Unknown: the biological process SET6 participates in and its localization.
Significance: Without a biological process or localization, SET6 cannot be placed in a pathway; its drug-conditional phenotype hints at a role only indirectly.
What would resolve it: Fluorescent-protein tagging / microscopy to determine localization, and phenotypic profiling (including in the presence of ergosterol-biosynthesis inhibitors and in sensitized genetic backgrounds) to define a biological process.
Provenance (the field's own admissions):
SET domain protein of unknown function; deletion heterozygote is sensitive to compounds that target ergosterol biosynthesis, may be involved in compound availability
Loading supporting content…
Download this section (compressed HTML)Loading supporting content…
Download this section (compressed HTML)Loading supporting content…
Download this section (compressed HTML)